Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen, Inc. | 2.59% | 282.27 | 1.4% | $841.66m | |
| AMGN | Amgen, Inc. | 1.08% | 220.86 | 1.3% | $515.75m | |
| CELG | Celgene Corp. | 0.00% | 110.02 | 1.3% | $466.76m | |
| GILD | Gilead Sciences, Inc. | 1.98% | 65.07 | 1.0% | $400.35m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 2.34% | 209.80 | 1.9% | $313.89m | |
| ILMN | Illumina, Inc. | 2.53% | 305.99 | 3.5% | $311.32m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.92% | 344.87 | 2.6% | $267.68m | |
| EXAS | EXACT Sciences Corp. | 3.55% | 82.05 | 24.0% | $209.78m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.34% | 108.37 | 2.0% | $179.80m | |
| SGEN | Seattle Genetics, Inc. | 1.29% | 114.75 | 6.1% | $136.96m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.71% | 75.04 | 4.3% | $123.64m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.05% | 97.46 | 14.6% | $115.38m | |
| A | Agilent Technologies, Inc. | 1.95% | 78.26 | 1.6% | $101.36m | |
| NBIX | Neurocrine Biosciences, Inc. | 2.89% | 113.05 | 5.0% | $90.40m | |
| BGNE | BeiGene Ltd. | 0.94% | 198.25 | 2.1% | $88.64m |
Company Profile
BioMarin Pharmaceutical, Inc. is a biotechnology company, which develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its products include Aldurazyme, Brineura, Kuvan, Naglazyme, Palynziq and Vimizim. The company was founded by Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.